TSVT - 2seventy bio GAAP EPS of -$2.55 beats by $0.80 revenue of $16.03M beats by $5.64M March, 22 2022 07:59 AM 2seventy bio Inc. 2seventy bio press release (NASDAQ:TSVT): Q4 GAAP EPS of -$2.55 beats by $0.80. Revenue of $16.03M (+61.8% Y/Y) beats by $5.64M. For further details see: 2seventy bio GAAP EPS of -$2.55 beats by $0.80, revenue of $16.03M beats by $5.64M